Patents by Inventor Licia Selleri

Licia Selleri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6175000
    Abstract: In accordance with the present invention, there is provided an isolated peptide having the characteristics of human trithorax protein (as well as DNA encoding same, antisense DNA derived therefrom and antagonists therefor). The invention peptide is characterized by having a DNA binding domain comprising multiple zinc fingers and at least 40% amino acid identity with respect to the DNA binding domain of Drosophila trithorax protein and at least 70% conserved sequence with respect to the DNA binding domain of Drosophila trithorax protein, and wherein said peptide is encoded by a gene located at chromosome 11 of the human genome at q23. Also provided are methods for the treatment of subject(s) suffering from immunodeficiency, developmental abnormality, inherited disease, or cancer by administering to said subject a therapeutically effective amount of one of the above-described agents (i.e., peptide, antagonist therefor, DNA encoding said peptide or antisense DNA derived therefrom).
    Type: Grant
    Filed: May 13, 1993
    Date of Patent: January 16, 2001
    Assignee: The Salk Institute for Biological Studies
    Inventors: Glen A. Evans, Malek Djabali, Licia Selleri, Pauline Parry
  • Patent number: 5891627
    Abstract: Nucleotide sequence defining a polymorphic locus useful for identification of an individual. Also disclosed are oligonucleotide primers useful in amplification of the locus and methods for detecting the amplified locus.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: April 6, 1999
    Assignee: The Salk Institute for Biological Studies
    Inventors: Glen A. Evans, Licia Selleri, James H. Eubanks
  • Patent number: 5679517
    Abstract: Methods for identifying the existence, and optionally the location, of chromosomal aberration(s) in the genome of an organism are disclosed. Intact, chromosomal DNA is hybridized with one or more clones constructed from chromosomal DNA derived from an organism of the same species as the organism to be tested. By identifying the existence of a chromosomal aberration, the susceptibility of an individual to certain disease states can be predicted, and/or the nature of a given disease state can be ascertained with greater certainty.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: October 21, 1997
    Assignee: The Salk Institute For Biological Studies
    Inventors: Glen A. Evans, Licia Selleri, Gary G. Hermanson